Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2011-08-16
2011-08-16
Kolker, Daniel E (Department: 1649)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C514S002100, C424S570000
Reexamination Certificate
active
07998460
ABSTRACT:
Methods are provided for protecting an individual from adverse long-term effects of neuroinflammation. Inflammatory blockade maintains neurogenesis capability after cranial irradiation by reducing the negative effects of activated microglia on neural precursor cells. These findings have broad implications for a variety of diseases of cognition, involving neuroinflammation and precursor cell dysfunction.
REFERENCES:
patent: 2003/0203844 (2003-10-01), Delfani et al.
Tada et al. Neurosurgery 41: 209-219, 1997—online publication 1-18 pages.
Ferencik et al. Bratisl Lek Listy 102(3): 123-32, 2001.
Efsen et al. Hepatology 33: 713-721, 2001.
Hull et al. Curr Med Chem 9: 83-89, 2002.
Richardson et al. (Soc for Neurosc Meeting, Abstract 304.12, 2002).
Yang et al. NeuroRep 9: 3477-3480, 1998.
Monje et al. Nat Med 8: 955-962, 2002.
Kondo et al. Brain Res 791: 352-356, 1998.
Plevova, Radiol Oncol 36: 33-40, 2002.
Kyrkanides et al. Mol Brain Res. 104: 159-169, 2002.
Liu et al. J Neurosc 18: 7768-7778, 1998.
Price et al. (J Med Primatol 30: 81-87, 2001).
Emmerling et al (Inflamm res: 47: 145-147, 1998).
de Jong et al. (Ned Tijdschr Geneeskd 146: abstract, 2002).
Aboody, K., et al., “Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas,” (2000)PNAS, 97(23):12846-12851.
Gage, “Mammalian neural stem cells,” (2000)Science, 287:1433-1438.
Hoehm, B.D., et al., “Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin,” (2005)Stroke, 36:2718-2724.
Monje, M.L., et al., “Inflammatory blockade restores adult hippocampal neurogenesis,” (2003)Science, 302:1760-1765.
Monje, M.L., et al., “Irradiation induces neural precursor-cell dysfunction,” (2002)Nature Medicine, 8(9):955-962.
Rogers, J., et al., “Clinical trial of indomethacin in Alzheimer's disease,” (1993)Neurology, 43:1609-1611.
Sasaki, T., et al., “Implication of cyclooxygenase-2 on enhanced proliferaton of neural progenitor cells in the adult mouse hippocampus after ischemia,” (2003)Journal of Neuroscience Research, 72:461-471.
Yuzawa, et al., “APC0576: A novel small molecule, immunosuppressive agent effective in primate models,” (2003)Transplantation, 75(9):1463-1468.
Hoehn et al., “Recovery of Neurogenesis following stroke after anti-inflammatory treatment,” 33rd Annual Meeting of the Society of Neuroscience, Society for Neuroscience Abstract Viewer and Itinerary Planner, 2003, Abstract No. 844.12.
Sasaki et al., “Implication of Cyclooxygenase-2 on Enhanced Proliferation of Neural Progenitor Cells in the Adult Mouse Hippocampus After Ischemia,” J Neurosci. Res., 2003, 72(4):461-471.
Monje Michelle L.
Palmer Theo D.
Alcamo Elizabeth A.
Bozicevic Field & Francis LLP
Dutt Aditi
Kolker Daniel E
Sherwodd Pamela J.
LandOfFree
Prevention of deficits in neurogenesis with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of deficits in neurogenesis with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of deficits in neurogenesis with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2779112